Clinical trialNo phase (not a drug trial)Completed
Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer
Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer; a Single Center, Non-randomized, Feasibility Study in an Open Surgical Setting - the SLOTH1 Study
- Outcome
- Finished, no results posted
- Phase
- No phase (not a drug trial)
- Status
- Completed
- Study type
- Interventional
- Start
- 13 December 2021
- Ended
- 18 February 2024
- Enrollment
- 3 participants
- Sites
- 1
- Primary outcomes
- Average tumour dose by SPECT imaging
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 11 April 2024
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
This is a feasibility study in which patients with pancreatic cancer are treated with intratumoral holmium microsphere injections.